PREVENT: Promus BTK
clinical trial
Press Enter · cited answer in seconds
0 sources
PREVENT: Promus BTK
Summary
PREVENT: Promus BTK is a clinical trial[1].
Key Facts
- PREVENT: Promus BTK is in the country of Promus BTK — country (P17): Belgium[2].
- PREVENT: Promus BTK is in the country of Promus BTK — country (P17): Germany[3].
- PREVENT: Promus BTK is in the country of Promus BTK — country (P17): New Zealand[4].
- PREVENT: Promus BTK's instance of is recorded as Promus BTK — instance of (P31): clinical trial[5].
- PREVENT: Promus BTK's start time is recorded as +2012-08-31T00:00:00Z[6].
- PREVENT: Promus BTK's end time is recorded as +2016-01-31T00:00:00Z[7].
- PREVENT: Promus BTK's main subject is recorded as Promus BTK — main subject (P921): drug-eluting stent[8].
- PREVENT: Promus BTK's number of participants is recorded as {'unit': '1', 'amount': '+70'}[9].
- PREVENT: Promus BTK's title is recorded as PREVENT: a Prospective, Multi-center, Monitored Trial Investigating the Implant of the Promus Everolimus-Eluting Stent System in Critically Ischemic Lesions BTK[10].
- PREVENT: Promus BTK's short name is recorded as PREVENT[11].
- PREVENT: Promus BTK's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- PREVENT: Promus BTK's ClinicalTrials.gov ID is recorded as NCT01500070[13].
- PREVENT: Promus BTK's research intervention is recorded as Promus BTK — research intervention (P4844): everolimus[14].
- PREVENT: Promus BTK's research intervention is recorded as Promus BTK — research intervention (P4844): sirolimus[15].
- PREVENT: Promus BTK's clinical trial phase is recorded as Promus BTK — clinical trial phase (P6099): phase II clinical trial[16].
- PREVENT: Promus BTK's research site is recorded as Promus BTK — research site (P6153): Imeldaziekenhuis[17].
- PREVENT: Promus BTK's research site is recorded as Promus BTK — research site (P6153): Auckland City Hospital[18].
- PREVENT: Promus BTK's research subject recruitment status is recorded as Promus BTK — research subject recruitment status (P8005): completed[19].
- PREVENT: Promus BTK's study type is recorded as Promus BTK — study type (P8363): interventional study[20].